{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-005427","form_type":"8-K","ticker":"PROF","cik":"0001628808","company_name":"Profound Medical Corp.","filed_at":"2025-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.518983+00:00","generated_at":"2026-05-17T13:13:57.064396+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Profound Medical reports Q2 net loss of $15.7M; revenue flat at $2.2M; maintains 70-75% FY growth guidance","bullets":["Net loss of $15.7M ($0.52/share) vs $6.9M ($0.28/share) in Q2 2024; revenue unchanged at $2.2M.","Gross margin improved to 73% from 64% on manufacturing efficiencies; operating expenses rose to $15.4M from $9.3M.","Same-store TULSA-PRO procedure volumes up 10% sequentially; pipeline of 80 new systems in qualifying stages.","CEO cites short-term capital sales delays but reaffirms FY 2025 revenue growth target of 70-75% YoY.","Cash position $35.2M; first commercial BPH treatment with TULSA-AI Volume Reduction Module conducted; full launch expected Q4 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-005427","json":"https://secwatch.observer/filing/0001171843-25-005427.json","markdown":"https://secwatch.observer/filing/0001171843-25-005427.md","text":"https://secwatch.observer/filing/0001171843-25-005427.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628808/000117184325005427/0001171843-25-005427-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628808/000117184325005427/f8k_081425.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T13:13:57.064396+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}